title: Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies.
abstract: A total of 21 patients with hematologic malignancies were given thiabendazole for treatment of strongyloidiasis. Fifteen patients were cured. Since there were no relapses, it is unlikely that maintenance therapy has a role in the management of strongyloidiasis in this population of patients.
authors.affiliation: Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Brazil.
authors.forename: R
authors.initials: R
authors.lastname: Schaffel
authors.forename: M
authors.initials: M
authors.lastname: Nucci
authors.forename: R
authors.initials: R
authors.lastname: Portugal
authors.forename: M B
authors.initials: MB
authors.lastname: Castro
authors.forename: S B
authors.initials: SB
authors.lastname: Ferreira
authors.forename: L
authors.initials: L
authors.lastname: Almeida
authors.forename: N
authors.initials: N
authors.lastname: Spector
authors.forename: W
authors.initials: W
authors.lastname: Pulcheri
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000969:Antinematodal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D004244:Dizziness / Q000139:chemically induced; D005260:Female; D005500:Follow-Up Studies; D019337:Hematologic Neoplasms / Q000150:complications*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D013322:Strongyloidiasis / Q000150:complications / Q000188:drug therapy*; D013827:Thiabendazole / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000969:Antinematodal Agents; D013827:Thiabendazole